GlassScriptPhysician profile
Yash Jaydev Avashia
NPI 1346583051
$7,049.23
in general payments reported to CMS, 2019-2025
14 companies · $957 in 2025
The $957 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $944 · 2020: $2,159 · 2021: $1,357 · 2022: $476 · 2023: $495 · 2024: $662 · 2025: $957.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,113.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $1,910.52 | 2019-2023 | |
| Sientra, INC. | $1,223.83 | 2019-2021 | |
| Abbvie INC. | $1,171.14 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Allergan, INC. | $984.70 | 2019-2022 | |
| Integra Lifesciences Corporation | $459.73 | 2023-2024 | Integra, Durasorb Monofilament Mesh, Surgimend |
| Merz North America, INC. | $234.92 | 2021-2025 | |
| Bard Peripheral Vascular, INC. | $182.89 | 2021 | |
| Davol INC. | $180.77 | 2022 | |
| Tepha INC | $164.41 | 2019 | |
| Galderma Laboratories, L.P. | $155.66 | 2022-2024 | |
| Becton, Dickinson and Company | $139.06 | 2022 | |
| Motiva USA, LLC | $124.57 | 2025 | |
| Tela Bio, INC. | $67.83 | 2020-2024 | Ovitex 2s |
| Polarityte, INC. | $49.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yash Avashia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.